MedTrace Logo

3D Visualization System for Vitreoretinal Diseases in Highly Myopic Eyes

NCT05367193 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2024-06-17

No results posted yet for this study

Summary

To investigate the surgical outcomes and intraoperative parameters evaluation of 3D visualization system for vitreoretinal diseases in highly myopic eyes

Conditions

  • Patients With Highly Myopic Eyes

Interventions

PROCEDURE

pars plana vitrectomy

pars plana vitrectomy for vitreoretinal disease in highly myopic eyes

DEVICE

NGENUITY® 3D Visualization System (Alcon, TX, USA)

Injection of ICG to stain internal limiting membrane

Sponsors & Collaborators

  • Alcon Research

    collaborator INDUSTRY

  • National Taiwan University Hospital

    lead OTHER

Principal Investigators

  • Ho Tzyy-Chang, MD · National Taiwan University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-10-07
Primary Completion
2023-03-16
Completion
2023-03-16

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05367193 on ClinicalTrials.gov